Prucalopride Tablet, Film Coated
Product Images NDC 69238-2698

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride (NDC 69238-2698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Prucalopride Tablets 1)

Chemical structure diagram of prucalopride succinate, showing the molecular arrangement of the prucalopride component and the succinate salt.*

FDA Label Image

1mg 30ct Label (Prucalopride Tablets 2)

Prucalopride 1 mg film-coated tablets label by Amneal Pharmaceuticals NY LLC. The label includes dosage information as one tablet once daily, package size of 30 tablets, and storage instructions. Manufacturer is Ritsa Pharma Private Limited, Hyderabad, India, with distribution by Amneal Pharmaceuticals LLC in New Jersey.*

FDA Label Image

2mg 30ct Label (Prucalopride Tablets 3)

Prucalopride 2 mg film-coated tablets label by Amneal Pharmaceuticals NY LLC. The label indicates prescription use with 30 tablets per container. It provides storage instructions, manufacturer details (Ritsa Pharma Private Limited), and barcode. The label emphasizes a usual dose of one tablet once daily.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.